 | Articles: General Pharma
|
 Receive daily email updates on: General Pharma
|
 | | Sponsor |
New England Journal of Medicine Reports ISENTRESS(raltegravir), Merck's First in Class Integrase Inhibitor, Suppressed HIV-1 Viral Load and Increased CD4 Cell Counts through 48-Weeks in Treatment-Experienced Adult Patients When Taken with Other Anti-HIV Medicines
Merck & Co., 07/24/08
Teva Completes Acquisition of Bentley Pharmaceuticals
Teva Pharmaceutical Industries, 07/24/08
Teva Introduces First Generic Lamictal Tablets in the United States
Teva Pharmaceutical Industries, 07/24/08
Genzyme Reports Strong Second-Quarter Growth
Genzyme, 07/24/08
Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
Nabi Biopharmaceuticals, 07/24/08
CryoCath Arctic Front(R) Results Published in JACC
Corporate News Releases, 07/24/08
Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations
Corporate News Releases, 07/24/08
FDA Clears Osmetech's Warfarin Sensitivity Test and New eSensor(R) XT-8 Platform
Corporate News Releases, 07/24/08
Pioneer(R) Surgical Technology, Inc. Announces the Market Launch of the SlimFuse(TM) Anterior Cervical Plate System
Corporate News Releases, 07/24/08
IMI Intelligent Medical Implants AG Announces the Appointment Robert J. Hill as Vice President of Operations
Corporate News Releases, 07/24/08
|
|
Receive daily email updates on: General Pharma
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
